Journal article
Current challenges and novel treatment strategies in double hit lymphomas
MA Anderson, A Tsui, M Wall, DCS Huang, AW Roberts
Therapeutic Advances in Hematology | SAGE PUBLICATIONS LTD | Published : 2016
Abstract
High-grade B-cell lymphomas with recurrent chromosomal break points have been termed ‘double hit lymphoma’ (DHL). The most commonly seen DHL is diffuse large B-cell lymphoma (DLBCL) with t(14;18) and t(8;14) or t(8;22) resulting in overexpression of BCL2 and MYC, respectively. The increased proliferation due to MYC overexpression, without the ability for an apoptotic brake as a result of BCL2 overexpression, results in ‘the perfect storm of oncogenesis’. Thus this disease presents a number of diagnostic and therapeutic challenges for the hematologist. The first and foremost challenge is to recognize the DHL. As different morphological entities can be affected it is incumbent on pathologists ..
View full abstractGrants
Awarded by National Health and Medical Research Council of Australia
Funding Acknowledgements
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: MAA is supported by a Jill and Ross Webster Bequest Fellowship. DCHS and AWR are supported by Fellowships from the National Health and Medical Research Council of Australia (grant numbers 1043149 and 1079560, respectively). This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS.